The BCG Vaccine is a vaccine containing bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis, with non-specific immunoadjuvant and immunotherapeutic activities. Although the mechanism of its anti-tumor activity is unclear, immunization with BCG vaccine likely activates a Th1 cytokine response that includes the induction of interferon. Vaccination with BCG vaccine may be immunoprotective against infection with Mycobacterium tuberculosis.
The success and challenges of developing different tuberculosis (TB) vaccine types.
Scientists at the University of Pittsburgh School of Medicine have discovered a tuberculosis (TB) vaccination strategy that could prevent the leading cause of death among people worldwide living with HIV.
Researchers examined the effect of Bacillus Calmette-Guérin (BCG) vaccination on attenuating herpes labialis (cold sore) recurrences.
The Bacillus Calmette-Guérin (BCG) vaccine-;which prevents tuberculosis-;offers multiple beneficial effects, and it's currently a recommended therapy for non–muscle-invasive bladder cancer.
Researchers investigated whether BCG vaccines could lower COVID-19 burden.
Researchers evaluated whether the BCG vaccine could protect healthcare workers against coronavirus disease 2019.
Researchers assessed the impact of BCG vaccination on the protection provided by SARS-CoV-2 vaccination.
The tuberculosis vaccine (or BCG vaccine) does not protect elderly with co-morbidities against disease symptoms caused by a coronavirus infection.
The World Health Organization announces the creation of the TB Vaccine Accelerator Council.
Announcing a new article publication for Zoonoses journal. This study was aimed at screening differentially expressed genes (DEGs) and exploring the potential immune mechanism induced by the Bacillus Calmette-Guerin (BCG) vaccine in a humanized mouse model.
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, primarily causes mild to moderate upper-respiratory tract illness. However, some individuals with COVID-19 develop severe infections and require hospital admission.
In a new study, researchers assessed the ecological association suggesting the efficacy of bacillus Calmette-Guerin (BCG) vaccination against COVID-19.
Researchers identified type 3 vaccine-derived poliovirus (VDPV) in an infant.
A new study reports the effect of the infant gut microbiome on vaccine efficacy.
A modified tuberculosis (TB) vaccine developed at Texas Biomed could help treat a form of bladder cancer, called non-muscle invasive bladder cancer, without strong side effects.
A recent article demonstrated that BCG vaccinations might offer a platform for protection against emerging SARS-CoV-2 variants and other pathogenic infections in type 1 diabetics.
The immune boosting benefits of a tuberculosis vaccine can be seen in infants more than one year after vaccination, according to a new study.
In this interview, we speak to Charles Wells from Gates MRI about their current research into tuberculosis (TB) as well as the recent updated guidelines for TB care.
The University of Oxford has begun recruiting for a Phase I trial with a tuberculosis vaccine in human volunteers at Oxford to develop a new way to test the efficacy of future TB vaccines - with the first volunteers being challenged today (Wednesday).
Researchers evaluated the impact of the OPV on the incidence of COVID-19.